ObjectivesGiant omphalocele often represents a major surgical challenge and is reported with high mortality and morbidity rates. The aim of this study was to assess the outcome of neonates with giant omphalocele managed with early operative surgical treatment, and subsequently to identify possible factors that could alter the prognosis. MethodsWe reviewed the medical records of 29 consecutive newborns with prenatally diagnosed giant omphalocele. In these cases one of two procedures had been performed: either staged closure after silo, or immediate closure with a synthetic patch. The cases were separated into 2 groups: Isolated giant omphalocele (IO group) and giant omphalocele associated with malformation (NIO group). ResultsInfants in the IO group had a lower size of the omphalocele (p<0,001), a shorter hospital stay (95 days [45-915] vs. 41.5 days [10-110] p= 0, 02), and a shorter median ventilation length (10 days [1-33] vs. 27, 5 [6-65] p = 0, 05). In the NIO group, 5 cases displayed a significantly more difficult course than the others. They were compared to the remaining cases for prenatal and anatomic features. Four factors associated with greater morbidity were identified:-Associated cardiopathies (septal defects)(100% vs. 15%, p =0,001),-Associated congenital anomalies (100% vs. 10%, p <0.001),-Omphalocele containing both liver and bowel (80 vs. 30%, p = 0, 04),-Mean omphalocele/abdominal circumference (OC/AC) ratio 0, 82 [0, 60-1, 25] vs. 0, 76 [0,51-1, 20], p=0, 05. ConclusionsIsolated omphalocele, even containing the whole liver, has a very good prognosis with early surgical treatment. Without associated anomalies, 95% of giant omphaloceles can be discharged with a median of 41.5 days in hospital. However, associated anomalies (especially cardiopathies) may burden the prognosis and should be both carefully assessed during pregnancy and taken into account in parental information. Type of StudyRetrospective Study Level of EvidenceLevel I.
Read full abstract